Search arXiv⌕ Search

arXiv subjects

Christopher James Langmead

Publications and source records attributed to Christopher James Langmead.

5 recordsLinked to original sources

Multi-Objective Amortized CDRH3 Sequence Sampling Diversifies Promising Antibody Candidates

Antibody therapeutics have transformed treatment across diverse therapeutic areas and have become central to modern medicine. While recent machine learning approaches aim to accelerate antibody discovery through structure-based design and target-affinity optimization, successful candidates must also satisfy broad developability constraints, including structural compatibility, low immunogenicity, and favorable biophysical properties, while remaining sufficiently diverse to provide sufficient coverage of design space to mitigate later-stage development failures. We introduce a preference-conditioned multi-objective generative flow network (GFN) fine-tuning pipeline for fixed-framework CDRH3 loop redesign that fine-tunes a biological sequence model against many inexpensive proxies covering backbone compatibility, sequence likelihood, immunogenicity risk, novelty, and developability liabilities. It combines up to fourteen predictive rewards in a single policy trained to sample CDRH3 loops across 623 SAbDab antibody structures, leveraging a reward reduction strategy to preserve Pareto dominance under this learned map. We also introduce a novel autoregressive span-in-filling variant of AMPLIFY-350M that serves both as a scaffold-conditioned CDRH3 generation prior and as a direct conditional likelihood scorer. We evaluated reward scores, diversity, and design quality on loops sampled on 45 held-out antibody complexes to assess structural consistency, confidence, aggregation propensity, stability, and antigen binding. Compared with the inverse-folding methods ProteinMPNN and ESM-IF, our approach produces roughly 10x more distinct acceptable candidates per design at 50% sequence identity, while holding 10% of the 14-objective Pareto front pooled across methods, trading per-sample quality for greater exploration of novel possible structures.

cs.CE↗

Structure-Aligned Protein Language Model

Protein language models (pLMs) pre-trained on vast protein sequence databases excel at various downstream tasks but often lack the structural knowledge essential for some biological applications. To address this, we introduce a method to enrich pLMs with structural knowledge by leveraging pre-trained protein graph neural networks (pGNNs). First, a latent-level contrastive learning task aligns residue representations from pLMs with those from pGNNs across multiple proteins, injecting inter-protein structural information. Additionally, a physical-level task integrates intra-protein information by training pLMs to predict structure tokens. Together, the proposed dual-task framework effectively incorporates both inter- and intra-protein structural knowledge into pLMs. Given the variability in the quality of protein structures in PDB, we further introduce a residue loss selection module that uses a small model trained on high-quality structures to select reliable yet challenging residue losses for the pLM to learn. Applying our structure alignment method as a simple, lightweight post-training step to the state-of-the-art ESM2 and AMPLIFY yields notable performance gains. These improvements are consistent across a wide range of tasks, including substantial gains in deep mutational scanning (DMS) fitness prediction and a 59% increase in P@L for ESM2 650M contact prediction on CASP16. Furthermore, we demonstrate that these performance gains are robust, scaling with model sizes from 8M to 650M and extending to different downstream tasks.

cs.LG↗

Peptide Binding Classification on Quantum Computers

We conduct an extensive study on using near-term quantum computers for a task in the domain of computational biology. By constructing quantum models based on parameterised quantum circuits we perform sequence classification on a task relevant to the design of therapeutic proteins, and find competitive performance with classical baselines of similar scale. To study the effect of noise, we run some of the best-performing quantum models with favourable resource requirements on emulators of state-of-the-art noisy quantum processors. We then apply error mitigation methods to improve the signal. We further execute these quantum models on the Quantinuum H1-1 trapped-ion quantum processor and observe very close agreement with noiseless exact simulation. Finally, we perform feature attribution methods and find that the quantum models indeed identify sensible relationships, at least as well as the classical baselines. This work constitutes the first proof-of-concept application of near-term quantum computing to a task critical to the design of therapeutic proteins, opening the route toward larger-scale applications in this and related fields, in line with the hardware development roadmaps of near-term quantum technologies.

quant-ph↗

Deep Normed Embeddings for Patient Representation

We introduce a novel contrastive representation learning objective and a training scheme for clinical time series. Specifically, we project high dimensional EHR. data to a closed unit ball of low dimension, encoding geometric priors so that the origin represents an idealized perfect health state and the Euclidean norm is associated with the patient's mortality risk. Moreover, using septic patients as an example, we show how we could learn to associate the angle between two vectors with the different organ system failures, thereby, learning a compact representation which is indicative of both mortality risk and specific organ failure. We show how the learned embedding can be used for online patient monitoring, can supplement clinicians and improve performance of downstream machine learning tasks. This work was partially motivated from the desire and the need to introduce a systematic way of defining intermediate rewards for Reinforcement Learning in critical care medicine. Hence, we also show how such a design in terms of the learned embedding can result in qualitatively different policies and value distributions, as compared with using only terminal rewards.

cs.LG↗

Unifying Cardiovascular Modelling with Deep Reinforcement Learning for Uncertainty Aware Control of Sepsis Treatment

Sepsis is a potentially life threatening inflammatory response to infection or severe tissue damage. It has a highly variable clinical course, requiring constant monitoring of the patient's state to guide the management of intravenous fluids and vasopressors, among other interventions. Despite decades of research, there's still debate among experts on optimal treatment. Here, we combine for the first time, distributional deep reinforcement learning with mechanistic physiological models to find personalized sepsis treatment strategies. Our method handles partial observability by leveraging known cardiovascular physiology, introducing a novel physiology-driven recurrent autoencoder, and quantifies the uncertainty of its own results. Moreover, we introduce a framework for uncertainty aware decision support with humans in the loop. We show that our method learns physiologically explainable, robust policies that are consistent with clinical knowledge. Further our method consistently identifies high risk states that lead to death, which could potentially benefit from more frequent vasopressor administration, providing valuable guidance for future research

cs.LG↗